| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Revenue | $25.85B | -3.0% |
| Cost of Revenue | $16.88B | -4.7% |
| Gross Profit | $8.97B | +0.5% |
| R&D Expense | $150.0M | +2.0% |
| SG&A Expense | $7.29B | +67.3% |
| Operating Income | $1.68B | -63.2% |
| Interest Expense | $912.0M | +0.0% |
| Pre-tax Income | $856.0M | -76.4% |
| Income Tax | -$1.89B |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.33B | -4.7% |
| Accounts Receivable | $2.15B | +1.7% |
| Inventory | $3.38B | -6.6% |
| Current Assets | $7.66B | -3.5% |
| Total Assets | $88.29B | -2.3% |
| Current Liabilities | $7.25B | -9.8% |
| Long-term Debt | $19.21B | -0.9% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.18B | +5.2% |
| Capital Expenditures | $1.02B | +1.1% |
| Investing Cash Flow | -$1.02B | -11.7% |
| Financing Cash Flow | -$3.01B | -12.3% |
| Free Cash Flow | $3.16B | +6.6% |
| -340.2% |
| Net Income | $2.74B | -3.9% |
| EPS (Basic) | $2.27 | -2.6% |
| EPS (Diluted) | $2.26 | -2.2% |
| Total Liabilities |
| $38.96B |
| -4.1% |
| Stockholders' Equity | $49.19B | -0.7% |